Cargando…
Improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group
OBJECTIVE: We aimed to re-examine mortality risk estimates for metabolically healthy obesity by using a ‘stable’ healthy non-obese referent group. DESIGN: Prospective cohort study. METHODS: Participants were 5427 men and women (aged 65.9 ± 9.4 years, 45.9% men) from the English Longitudinal Study of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967883/ https://www.ncbi.nlm.nih.gov/pubmed/28566442 http://dx.doi.org/10.1530/EJE-17-0217 |
_version_ | 1783325665106329600 |
---|---|
author | Hamer, Mark Johnson, William Bell, Joshua A |
author_facet | Hamer, Mark Johnson, William Bell, Joshua A |
author_sort | Hamer, Mark |
collection | PubMed |
description | OBJECTIVE: We aimed to re-examine mortality risk estimates for metabolically healthy obesity by using a ‘stable’ healthy non-obese referent group. DESIGN: Prospective cohort study. METHODS: Participants were 5427 men and women (aged 65.9 ± 9.4 years, 45.9% men) from the English Longitudinal Study of Ageing. Obesity was defined as body mass index ≥30 kg/m(2) (vs non-obese as below this threshold). Based on blood pressure, HDL cholesterol, triglycerides, glycated hemoglobin and C-reactive protein, participants were classified as ‘healthy’ (0 or 1 metabolic abnormality) or ‘unhealthy’ (≥2 metabolic abnormalities). RESULTS: Totally, 671 deaths were observed over an average follow-up of 8 years. When defining the referent group based on 1 clinical assessment, the unhealthy non-obese (hazard ratio (HR) = 1.22; 95% CI: 1.01, 1.45) and unhealthy obese (HR = 1.29; CI: 1.05, 1.60) were at greater risk of all-cause mortality compared to the healthy non-obese, yet no excess risk was seen in the healthy obese (HR = 1.14; CI: 0.83, 1.52). When we re-defined the referent group based on 2 clinical assessments, effect estimates were accentuated and healthy obesity was at increased risk of mortality (HR = 2.67; CI: 1.64, 4.34). CONCLUSION: An unstable healthy referent group may make ‘healthy obesity’ appear less harmful by obscuring the benefits of remaining never obese without metabolic dysfunction. |
format | Online Article Text |
id | pubmed-5967883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59678832018-05-30 Improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group Hamer, Mark Johnson, William Bell, Joshua A Eur J Endocrinol Clinical Study OBJECTIVE: We aimed to re-examine mortality risk estimates for metabolically healthy obesity by using a ‘stable’ healthy non-obese referent group. DESIGN: Prospective cohort study. METHODS: Participants were 5427 men and women (aged 65.9 ± 9.4 years, 45.9% men) from the English Longitudinal Study of Ageing. Obesity was defined as body mass index ≥30 kg/m(2) (vs non-obese as below this threshold). Based on blood pressure, HDL cholesterol, triglycerides, glycated hemoglobin and C-reactive protein, participants were classified as ‘healthy’ (0 or 1 metabolic abnormality) or ‘unhealthy’ (≥2 metabolic abnormalities). RESULTS: Totally, 671 deaths were observed over an average follow-up of 8 years. When defining the referent group based on 1 clinical assessment, the unhealthy non-obese (hazard ratio (HR) = 1.22; 95% CI: 1.01, 1.45) and unhealthy obese (HR = 1.29; CI: 1.05, 1.60) were at greater risk of all-cause mortality compared to the healthy non-obese, yet no excess risk was seen in the healthy obese (HR = 1.14; CI: 0.83, 1.52). When we re-defined the referent group based on 2 clinical assessments, effect estimates were accentuated and healthy obesity was at increased risk of mortality (HR = 2.67; CI: 1.64, 4.34). CONCLUSION: An unstable healthy referent group may make ‘healthy obesity’ appear less harmful by obscuring the benefits of remaining never obese without metabolic dysfunction. Bioscientifica Ltd 2017-05-30 /pmc/articles/PMC5967883/ /pubmed/28566442 http://dx.doi.org/10.1530/EJE-17-0217 Text en © 2017 The authors http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution 3.0 Unported License. (http://creativecommons.org/licenses/by/3.0/) . |
spellingShingle | Clinical Study Hamer, Mark Johnson, William Bell, Joshua A Improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group |
title | Improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group |
title_full | Improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group |
title_fullStr | Improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group |
title_full_unstemmed | Improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group |
title_short | Improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group |
title_sort | improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967883/ https://www.ncbi.nlm.nih.gov/pubmed/28566442 http://dx.doi.org/10.1530/EJE-17-0217 |
work_keys_str_mv | AT hamermark improvingriskestimatesformetabolicallyhealthyobesityandmortalityusingarefinedhealthyreferencegroup AT johnsonwilliam improvingriskestimatesformetabolicallyhealthyobesityandmortalityusingarefinedhealthyreferencegroup AT belljoshuaa improvingriskestimatesformetabolicallyhealthyobesityandmortalityusingarefinedhealthyreferencegroup |